218 related articles for article (PubMed ID: 38474580)
1. Recently Reported Biological Activities and Action Targets of Pt(II)- and Cu(II)-Based Complexes.
Maciel-Flores CE; Lozano-Alvarez JA; Bivián-Castro EY
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474580
[TBL] [Abstract][Full Text] [Related]
2. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
[TBL] [Abstract][Full Text] [Related]
3. Novel metals and metal complexes as platforms for cancer therapy.
Frezza M; Hindo S; Chen D; Davenport A; Schmitt S; Tomco D; Dou QP
Curr Pharm Des; 2010 Jun; 16(16):1813-25. PubMed ID: 20337575
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and antimicrobial activities of Cu(II), Co(II), Pt(II) and Zn(II) Complexes with N,O-chelating heterocyclic carboxylates.
Buczkowska M; Bodtke A; Lindequist U; Gdaniec M; Bednarski PJ
Arch Pharm (Weinheim); 2011 Sep; 344(9):605-16. PubMed ID: 21695713
[TBL] [Abstract][Full Text] [Related]
5. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties.
Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR
Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390
[TBL] [Abstract][Full Text] [Related]
6. An Evaluation of the Antioxidant and Anticancer Properties of Complex Compounds of Copper (II), Platinum (II), Palladium (II) and Ruthenium (III) for Use in Cancer Therapy.
Katarzyna M; Anna S; Zielinska-Blizniewska H; Ireneusz M
Mini Rev Med Chem; 2018; 18(16):1373-1381. PubMed ID: 29692246
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
8. New Platinum(IV) and Palladium(II) Transition Metal Complexes of s-Triazine Derivative: Synthesis, Spectral, and Anticancer Agents Studies.
Al-Khodir FAI; Abumelha HMA; Al-Warhi T; Al-Issa SA
Biomed Res Int; 2019; 2019():9835745. PubMed ID: 30906785
[TBL] [Abstract][Full Text] [Related]
9. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Metallocenes and Metal Complexes of Transition Elements from Groups 4 to 7.
Kostova I
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398576
[TBL] [Abstract][Full Text] [Related]
11. Metallopharmaceuticals in Therapy - A New Horizon for Scientific Research.
Chylewska A; Biedulska M; Sumczynski P; Makowski M
Curr Med Chem; 2018; 25(15):1729-1791. PubMed ID: 29210637
[TBL] [Abstract][Full Text] [Related]
12. Elaborated studies for the ligitional behavior of thiouracil derivative towards Ni(II), Pd(II), Pt(IV), Cu(II) and UO2 ² ions.
Abou-Melha KS
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Nov; 97():6-16. PubMed ID: 22743608
[TBL] [Abstract][Full Text] [Related]
13. Antitumor Activity of Pt(II), Ru(III) and Cu(II) Complexes.
Gałczyńska K; Drulis-Kawa Z; Arabski M
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751963
[TBL] [Abstract][Full Text] [Related]
14. NSAID-Based Coordination Compounds for Biomedical Applications: Recent Advances and Developments.
Santos ACF; Monteiro LPG; Gomes ACC; Martel F; Santos TM; Ferreira BJML
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269997
[TBL] [Abstract][Full Text] [Related]
15. Metal Ion Complexes with Pyrazoles, Aziridines and Diaziridines - Synthesis and Biological Activity.
Malinowska K; Lorenz IP; Sadowska B; Mucha P
Curr Med Chem; 2019; 26(4):648-663. PubMed ID: 29473492
[TBL] [Abstract][Full Text] [Related]
16. Metal Complexes as Promising Agents for Biomedical Applications.
Loginova NV; Harbatsevich HI; Osipovich NP; Ksendzova GA; Koval'chuk TV; Polozov GI
Curr Med Chem; 2020; 27(31):5213-5249. PubMed ID: 31038054
[TBL] [Abstract][Full Text] [Related]
17. A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies.
Adhikari S; Nath P; Das A; Datta A; Baildya N; Duttaroy AK; Pathak S
Biomed Pharmacother; 2024 Feb; 171():116211. PubMed ID: 38290253
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II).
Yadav AA; Patel D; Wu X; Hasinoff BB
J Inorg Biochem; 2013 Sep; 126():1-6. PubMed ID: 23707906
[TBL] [Abstract][Full Text] [Related]
19. Physico-Chemical Study of Mn(II), Co(II), Cu(II), Cr(III), and Pd(II) Complexes with Schiff-Base and Aminopyrimidyl Derivatives and Anti-Cancer, Antioxidant, Antimicrobial Applications.
Al-Fakeh MS; Alsikhan MA; Alnawmasi JS
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985526
[TBL] [Abstract][Full Text] [Related]
20. Group-10 metal complexes of biological molecules and related ligands: structural and functional properties.
Shimazaki Y; Yamauchi O
Chem Biodivers; 2012 Sep; 9(9):1635-58. PubMed ID: 22976959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
